NEWS: The Medicines and Healthcare products Regulatory Agency (#MHRA) in the UK said it has given a world-first approval to #Rotop's trofolastat, a PSMA-targeting agent for detecting lesions in men with #prostatecancer.
UK first to approve Rotop's prostate cancer imaging agent
The UK has given a world-first approval to Rotop's RoTecPSMA, a new imaging agent for detecting lesions in men with prostate cancer.
pharmaphorum.com
April 1, 2025 at 3:07 PM
NEWS: The Medicines and Healthcare products Regulatory Agency (#MHRA) in the UK said it has given a world-first approval to #Rotop's trofolastat, a PSMA-targeting agent for detecting lesions in men with #prostatecancer.